Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08934_nanopub.RAUdllls0sdHt5xStHJHV0GsrEw3ee21xeL834v7nDTs8#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB08934 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08934 label "SOFOSBUVIR [drugbank:DB08934]" assertion.
- drugbank:DB08934 seeAlso DB08934 assertion.
- drugbank:DB08934 seeAlso sovaldi.html assertion.
- drugbank:DB08934 seeAlso sovaldi-drug.htm assertion.
- drugbank:DB08934 identifier "drugbank:DB08934" assertion.
- drugbank:DB08934 description "Sofosbuvir is a medication used as part of combination therapy to treat hepatitis C virus (HCV) infection or HCV and HIV co-infection. Sofosbuvir is nucleotide analog inhibitor, which specifically inhibits HCV NS5B polymerase. Sofosbuvir was approved by the FDA in December 2013, and is marketed under the brand name Sovaldi." assertion.
- drugbank:DB08934 title "SOFOSBUVIR" assertion.
- drugbank:DB08934 bio2rdf_vocabulary:identifier "DB08934" assertion.
- drugbank:DB08934 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08934 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08934" assertion.
- drugbank:DB08934 bio2rdf_vocabulary:x-identifiers.org DB08934 assertion.
- drugbank:DB08934 drugbank_vocabulary:drugbank-id "DB08934" assertion.
- drugbank:DB08934 drugbank_vocabulary:x-cas cas:1190307-88-0 assertion.
- drugbank:DB08934 drugbank_vocabulary:x-kegg kegg:D10366 assertion.
- drugbank:DB08934 drugbank_vocabulary:x-wikipedia wikipedia:Sofosbuvir assertion.
- drugbank:DB08934 drugbank_vocabulary:x-ndc ndc:61958-1501-1 assertion.